2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer
- Sunday, October 25, 2026, 2:12
- PR Newswire
- Add a comment
SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ — Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune,…
About the Author
admin has written 21971 stories on this site.